top of page
W11 Ventures

W11 Ventures is a distinguished boutique advisory firm specializing in growth and innovation, dedicated to scaling startups and forward-thinking companies. It serves as a strategic connector between corporates and the innovation ecosystem, fostering long-term partnerships and empowering clients to create and invest in successful, innovative businesses. W11 Ventures takes a proactive approach, focused on delivering genuine value creation and sustainable growth.

 

W11 Ventures holds an exclusive position within the European research, innovation, and technology ecosystem, with a broad network and strong relationships with key stakeholders and organizations.

 

As a trusted strategic partner, W11 Ventures provides comprehensive support and guidance throughout the entire lifecycle of its portfolio companies, from seed and startup stages to scale-up, with a focus on business development, fundraising, growth, and exit strategies.

Operating across multiple sectors, W11 Ventures has expertise in ICT, life sciences, Healthtech, and MedTech.

 

Through its distinctive 360-degree approach, W11 Ventures adds significant value by bridging ecosystem gaps, fostering interconnections, and creating competitive advantages for its clients.

 

W11 Ventures

  • Services

    End to end startup and scalup advisory services - Scaling growth

     

    Technology and Digital Builder – Digital and AI spearhead

     

    Multi-fuctional advisory to industry – Competitiveness Booster

     

    Strategic Advisory to Investors & Funds – Venture Friends

     

    Government & Public Policy Advisory – Innovation for growth

  • Contact info

    W11 Ventures 

    28 Ammochostou, 1016 Nicosia, Cyprus

    Email: w11@w11ventures.com

    w: https://w11.ventures/

  • Member Contact Details

    Name & Position:

    Dr. Nikolas P. Mastroyiannopoulos, Director

    Email: mastroyiann@w11ventures.com

     

    Stavriana A. Kofteros, Director

    Email: kofteros@w11ventures.com

     

  • MEMBER ID

    W11/CY/13

  • Line of business:

    Venture Capital & funding

bottom of page